Templates by BIGtheme NET

HC Stocks in Hub! Zoetis Inc (ZTS), Celgene Corporation (CELG)

Shares of Zoetis Inc (NYSE:ZTS) ended Monday session in green amid volatile trading. The shares closed up +0.84 points or 1.62% at $52.69 with 3.12 million shares getting traded. Post opening the session at $52.00, the shares hit an intraday low of $52.00 and an intraday high of $53.14 and the price vacillated in this range throughout the day. The company has a market cap of $26.18 billion and the numbers of outstanding shares have been calculated to be 495.39 million shares.

Zoetis Inc (ZTS) announced that its Board of Directors declared a fourth quarter 2016 dividend payable to holders of the company’s common stock of $0.095 per share. The dividend is to be paid on Thursday, Dec. 1, 2016, to holders of record on Thursday, Nov. 3, 2016.

Shares of Celgene Corporation (NASDAQ:CELG) ended Monday session in green amid volatile trading. The shares closed up +0.20 points or 0.19% at $104.27 with 2.07 million shares getting traded. Post opening the session at $104.43, the shares hit an intraday low of $104.15 and an intraday high of $105.06 and the price vacillated in this range throughout the day. The company has a market cap of $80.85 billion and the numbers of outstanding shares have been calculated to be 775.11 million shares.

Celgene Corporation (CELG) announced that the data from a randomized, double-blind, multicenter, exploratory phase Ib study evaluating the effects of oral GED-0301 (mongersen) on both endoscopic and clinical outcomes in patients with active Crohn’s disease were accepted as a late breaking abstract at the United European Gastroenterology Week. The data are to be presented on October 18, 2016 at 6:27 a.m. ET.

Celgene will hold a conference call for the investment community to discuss the data on October 18, 2016, at 9 a.m. ET. The conference call will be available by webcast at www.celgene.com. An audio replay of the call will be available from noon ET October 18, 2016, until midnight ET October 25, 2016. To access the replay in the U.S., dial (855) 859-2056; outside the U.S. dial (404) 537-3406. The participant passcode is 87802096.

GED-0301 (mongersen) is an investigational compound that is not approved for any use in any country.

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*

ăn dặm kiểu NhậtResponsive WordPress Themenhà cấp 4 nông thônthời trang trẻ emgiày cao gótshop giày nữdownload wordpress pluginsmẫu biệt thự đẹpepichouseáo sơ mi nữhouse beautiful